Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines
about
Influenza vaccines for preventing cardiovascular diseaseVaccines for preventing influenza in healthy adultsEffectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analysesThe relative efficacy of trivalent live attenuated and inactivated influenza vaccines in children and adultsReduced reaction frequencies with repeated inactivated or live-attenuated influenza vaccinationEstimating influenza vaccine efficacy from challenge and community-based study dataThe Saudi Thoracic Society guidelines for influenza vaccinationsFacemasks, hand hygiene, and influenza among young adults: a randomized intervention trialEffectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communitiesEfficacy and correlates of protection for cell culture-derived and egg-derived inactivated influenza vaccines in younger adults.Influenza vaccines: an Asia-Pacific perspective.Hand hygiene and risk of influenza virus infections in the community: a systematic review and meta-analysis.Considerations for the rapid deployment of vaccines against H7N9 influenza.Distinct patterns of B-cell activation and priming by natural influenza virus infection versus inactivated influenza vaccination.Development of a vaccine against pandemic influenza viruses: current status and perspectives.Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza.Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico CityRefining the approach to vaccines against influenza A viruses with pandemic potential.Evaluation of the attenuation, immunogenicity, and efficacy of a live virus vaccine generated by codon-pair bias de-optimization of the 2009 pandemic H1N1 influenza virus, in ferrets.Influenza vaccines: from surveillance through production to protection.Update on antivirals and vaccines for seasonal and potential pandemic use.Properly folded bacterially expressed H1N1 hemagglutinin globular head and ectodomain vaccines protect ferrets against H1N1 pandemic influenza virusSeasonal Influenza Vaccination of Children Induces Humoral and Cell-Mediated Immunity Beyond the Current Season: Cross-reactivity With Past and Future Strains.M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice.Label-free, arrayed sensing of immune response to influenza antigens.Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance.Decreased serologic response in vaccinated military recruits during 2011 correspond to genetic drift in concurrent circulating pandemic A/H1N1 viruses.Antibodies against conserved antigens provide opportunities for reform in influenza vaccine designPreflucel®: a Vero-cell culture-derived trivalent influenza vaccine.Comparative study of influenza virus replication in MDCK cells and in primary cells derived from adenoids and airway epithelium.Oligomeric recombinant H5 HA1 vaccine produced in bacteria protects ferrets from homologous and heterologous wild-type H5N1 influenza challenge and controls viral loads better than subunit H5N1 vaccine by eliciting high-affinity antibodies.Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccineA simple Pichia pastoris fermentation and downstream processing strategy for making recombinant pandemic Swine Origin Influenza a virus Hemagglutinin protein.Cross-protective immune responses elicited by live attenuated influenza vaccinesChallenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete exampleBaseline levels of influenza-specific CD4 memory T-cells affect T-cell responses to influenza vaccines.Influence of prior influenza vaccination on antibody and B-cell responses.Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons.Incidence of influenza in healthy adults and healthcare workers: a systematic review and meta-analysis.School-located influenza vaccination decreases laboratory-confirmed influenza and improves school attendance.
P2860
Q24188037-C3CF1DD2-2740-4A32-92D7-7AD1C26C529DQ24197955-2BA82114-AEB3-4143-8261-A3CB801178B0Q24614487-D5E488E0-BF86-4D13-A25F-8EEF4D117C48Q24622008-DB29DC27-1045-4117-8DE0-9BDD2448A714Q24646377-1B2027CA-91A9-4F6F-9991-C24F9819271AQ24655781-D11534F7-FED3-4161-B39F-B5975BFFC6E6Q28394218-47FA0F1B-C7BA-4792-942A-DC024484225BQ28732425-3F74D060-9690-48A1-8E9A-7D6B57E311A9Q28741469-0665EBEB-6497-4563-AA41-2F47D517996DQ30226435-6EF5CE58-ADEE-4816-985D-FB419B2735EEQ30355443-CAFF3B85-706E-4DFF-97CB-14CB2057B386Q30359491-67825871-0BD1-4A05-A684-385C21AEEF7EQ30364635-A231DDB7-12B3-44B7-915C-1BC9E9571487Q30368005-0972493D-5CF5-4052-8B60-BF732A4419F7Q30373784-814FBDC4-76EA-461B-9C7D-47C4CF752579Q30377205-78200B24-E49C-4DF1-A6B0-05A28BC18D17Q30381410-2D5E5477-2386-478F-B185-C920F02CE31FQ30381595-9B920E84-F568-44AB-B8AA-E8E690E89AF2Q30382343-358EF225-F744-4517-961D-FED60904BA00Q30385118-04FD1055-AC8C-4AE0-BB87-ACA3C2A73A28Q30389265-B86604A5-340C-499F-B615-CB740E1058BCQ30391443-478D29B8-8097-4A2F-8379-E9ED6C12BF9FQ30392333-C05AC1B8-79FF-4593-B77C-6664E88DEF99Q30392561-537E3027-17B6-443A-B7FD-1558352B78E4Q30397233-B87BB29F-CE4B-4444-A30D-F82029B89519Q30400347-08536E7C-4CDD-4012-BFFF-39A77C5BF664Q30415565-1D46E6F8-0030-4E90-AC86-C991E2160978Q30416502-87AA593D-A409-4E64-8A3C-58ECF87286C5Q30420569-7DEA3960-A87F-40E4-9D7B-D2EC430851D7Q30420603-120DBC0B-3B3B-45FF-9A6B-C94690C8FAF9Q30420990-ED9C55FB-2A34-4B59-A454-01A54C03B44CQ30421413-530B7AFA-7D03-4673-A784-73D485974E24Q30424895-22384926-F9AF-4459-B149-1ACDAC6B748AQ30426540-388E581C-C920-416B-BF82-2CA263B0EF35Q30857100-2FF06324-988A-420A-B6F1-93CD6A3322E2Q33348541-B5080F03-E4B5-480F-9D2B-EF4D1831118BQ33361605-259716D9-99D5-4677-A650-18996FE82BBBQ33541763-24B76048-B9D1-402D-903B-43A5AB6C855AQ34058480-272B10DA-38B8-466B-A3F4-5E155FF97D37Q34137789-C793A9EA-260D-4DDA-A8D6-9326A113BC87
P2860
Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines
@en
Prevention of antigenically dr ...... and live attenuated vaccines.
@nl
type
label
Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines
@en
Prevention of antigenically dr ...... and live attenuated vaccines.
@nl
prefLabel
Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines
@en
Prevention of antigenically dr ...... and live attenuated vaccines.
@nl
P2093
P2860
P356
P1476
Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines
@en
P2093
Bhavya Rangarajan
Duane W Newton
Esther R Teich
John C Victor
Judy R Rotthoff
Laura L Baum
Matthew L Boulton
Rachel K Truscon
Suzanne E Ohmit
P2860
P304
P356
10.1056/NEJMOA061850
P407
P577
2006-12-01T00:00:00Z